MACROGENICS ($MGNX) posted quarterly earnings results for Q1 2026 on Wednesday, May 13th. The company reported earnings of -$0.58 per share, beating estimates of -$0.58 by $0.00. The company also reported revenue of $20,780,000, beating estimates of $15,351,000 by $5,429,000.
You can see Quiver Quantitative's $MGNX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MACROGENICS Hedge Fund Activity
We have seen 45 institutional investors add shares of MACROGENICS stock to their portfolio, and 53 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BELLEVUE GROUP AG removed 9,919,992 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $15,971,187
- FRAZIER LIFE SCIENCES MANAGEMENT, L.P. removed 3,175,665 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,112,820
- JEFFERIES FINANCIAL GROUP INC. removed 1,841,172 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $5,320,987
- BANK OF AMERICA CORP /DE/ added 1,628,274 shares (+777.4%) to their portfolio in Q4 2025, for an estimated $2,621,521
- RENAISSANCE TECHNOLOGIES LLC added 1,207,408 shares (+71.0%) to their portfolio in Q4 2025, for an estimated $1,943,926
- MORGAN STANLEY removed 828,217 shares (-83.7%) from their portfolio in Q4 2025, for an estimated $1,333,429
- JPMORGAN CHASE & CO removed 749,492 shares (-99.2%) from their portfolio in Q4 2025, for an estimated $1,206,682
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
MACROGENICS Price Targets
Multiple analysts have issued price targets for $MGNX recently. We have seen 2 analysts offer price targets for $MGNX in the last 6 months, with a median target of $7.5.
Here are some recent targets:
- Etzer Darout from Barclays set a target price of $6.0 on 04/20/2026
- Mayank Mamtani from B. Riley Securities set a target price of $9.0 on 04/10/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
